These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1568524)

  • 21. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
    Bakris GL; Weir MR; DeQuattro V; McMahon FG
    Kidney Int; 1998 Oct; 54(4):1283-9. PubMed ID: 9767545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial.
    Fallahzadeh MK; Dormanesh B; Sagheb MM; Roozbeh J; Vessal G; Pakfetrat M; Daneshbod Y; Kamali-Sarvestani E; Lankarani KB
    Am J Kidney Dis; 2012 Dec; 60(6):896-903. PubMed ID: 22770926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.
    O'Donnell MJ; Rowe BR; Lawson N; Horton A; Gyde OH; Barnett AH
    J Hum Hypertens; 1993 Aug; 7(4):327-32. PubMed ID: 8410923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of direct renin inhibitor monotherapy on proteinuria in overt diabetic nephropathy.
    Silaratana S; Sumransurp S; Duangchana S; Tasanarong A
    J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S18-23. PubMed ID: 23964439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lack of effect of ACE inhibition on severe proteinuria in diabetic nephropathy--a 6-month-long study].
    Hay U; Ludvik B; Gisinger C; Schernthaner G
    Schweiz Med Wochenschr; 1988 Feb; 118(5):165-9. PubMed ID: 3278375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
    Galle J; Schwedhelm E; Pinnetti S; Böger RH; Wanner C;
    Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of jiawei shenqi dihuang tang on the content of urinary protein in patients with diabetic nephropathy.
    Chen Y; Wei L; Ma M; Wu G; Zhang G; Wei Z
    J Tradit Chin Med; 1997 Sep; 17(3):184-6. PubMed ID: 10437191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adiponectin is positively associated with insulin resistance in subjects with type 2 diabetic nephropathy and effects of angiotensin II type 1 receptor blocker losartan.
    Guo LL; Pan Y; Jin HM
    Nephrol Dial Transplant; 2009 Jun; 24(6):1876-83. PubMed ID: 19164322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of proteinuria in diabetic patients with nephropathy].
    Satoh K
    Nihon Naika Gakkai Zasshi; 1989 Jul; 78(7):905-12. PubMed ID: 2794672
    [No Abstract]   [Full Text] [Related]  

  • 31. [Qualitative study of proteinuria in diabetic nephropathy].
    Faure Nogueras E; Blasco Comenge MC; Guillén Martínez G
    An Med Interna; 1991 Jul; 8(7):333-5. PubMed ID: 1932490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dramatic reduction of proteinuria in diabetic nephropathy by the use of spironolactone.
    Floyd HW
    J S C Med Assoc; 2012 Aug; 108(4):93-4. PubMed ID: 23270101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
    Matsubara M; Taguma Y; Saito T; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):411-6. PubMed ID: 1635286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term follow-up of the effect of captopril on severe proteinuria in hypertensive diabetic patients.
    Romero R; Salinas I; Teixidó J; Lucas A; Felip A; Sanmarti A
    J Hum Hypertens; 1990 Dec; 4(6):671-5. PubMed ID: 2096209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of urinary protein in diabetics; its clinical implications as a predictor of nephropathy.
    Suenaga K
    Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):43-52. PubMed ID: 2038131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary protein excretion and serum tumor necrosis factor in diabetic patients with advanced renal failure: effects of pentoxifylline administration.
    Navarro JF; Mora C; Rivero A; Gallego E; Chahin J; Macía M; Méndez ML; García J
    Am J Kidney Dis; 1999 Mar; 33(3):458-63. PubMed ID: 10070909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of continuous subcutaneous insulin infusion on renal function in type I diabetic patients with and without proteinuria.
    van Ballegooie E; de Jong PE; Donker AJ; Sluiter WJ
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():722-4. PubMed ID: 3991567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [IRMA-pRAcs: irbesartan in the treatment of microalbuminuria and proteinuria in patients with type 2 diabetes and hypertension-prospective observational study involving 38,016 patients in the general practice setting].
    Lehnert H; Bramlage P; Pittrow D; Kirch W
    MMW Fortschr Med; 2003 Oct; 145 Suppl 3():81-7. PubMed ID: 15490772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteinuria and activated T-lymphocytes in diabetic nephropathy.
    Bending JJ; Lobo-Yeo A; Vergani D; Viberti GC
    Diabetes; 1988 May; 37(5):507-11. PubMed ID: 3258834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urinary excretion and renal clearance of several specific plasma proteins in diabetics].
    Khristov V; Popova D; Kolebinov N
    Vutr Boles; 1987; 26(3):64-8. PubMed ID: 3617708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.